AzTrials
AzTrials

SleepNCT04505800

Tryptophan Supplementation to Improve Night Shift Workers' Health

A study testing Tryptophan supplement and Maltose in people with Sleep and Mood, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized cross-over double-blinded trial aims to investigate the health effect of oral l-tryptophan supplementation on workers who rotate night shift work, and to examine the influences of different frequencies and timings of supplementation on the health effects. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
Conditions the study is for
Sleep, Mood, Burnout
What is being tested?
Tryptophan supplement and Maltose
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteTaiwan
Study dates
1 Sep 2019to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age: adults >=20 y/o
  • Adults who had night shift schedule >1 month before enrollment, and will have similar night shift schedule in the following 2 months. (Eligible night shift schedule: >1 day of evening or night shift in a week)
  • People who will not have plans to travel to another time zone in the following 2-3 months
  • People who will plan to stay in the same job position for the following 3 months
  • People who have no experience in taking tryptophan or melatonin supplement in the past month
  • Body weight >= 50kg and <=80kg
  • Non-pregnant, non-breastfeeding, not taking contraceptives
  • Not under treatment of steroids, not taking sleeping pills

Who cannot join

  • diagnosis of renal or liver diseases
  • diagnosis of Cushing's Disease, Addison's disease
  • psychiatric diagnosis, such as depression and anxiety disorders
  • neurological diseases such as dementia, epilepsy, Parkinson's disease

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National Yang-Ming University

    Taipei, 112

Other trials in Taiwan

About this study

Official title: Chrononutrition of Using L-tryptophan Supplementation to Alleviate the Impacts of Night Shift Rotation on Circadian Hormones and Health Outcomes

This randomized cross-over double-blinded trial aims to investigate the health effect of oral l-tryptophan supplementation on workers who rotate night shift work, and to examine the influences of different frequencies and timings of supplementation on the health effects.

Read the detailed description

This study aims to investigate the health effect of oral l-tryptophan supplementation on workers who rotate night shift work, and to examine the influences of different frequencies and timings of supplementation on the health effects. Night shift work affects melatonin and cortisol variation, insomnia, mood issues, and metabolic syndrome. Short-term tryptophan supplementation was shown to improve melatonin, sleep quality, and cortisol response to acute stress. Little is known whether a longer term of longer-term tryptophan supplementation would alleviate the health impacts of night shift work. Nevertheless, melatonin and cortisol have their normal circadian patterns. Nothing is known about what temporal structure of tryptophan supplement would maximize its health effects on night shift workers melatonin and cortisol levels. We will conduct a double-blind cross-over randomized controlled trial to examine the benefits of oral tryptophan administration (3g/day, t.i.d.) on night shift workers' health outcomes: melatonin and cortisol levels, sleep quality, moods and work performance. We expect to reveal the health effect of tryptophan supplementation in night shift workers by using sophisticated study design.

Being tested
Tryptophan supplement, Maltose
Keywords
tryptophan, shift work, randomized trial, melatonin, cortisol
Medical subject headings
Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tryptophan supplementDietary supplement

    • Pure L-tryptophan in capsules (500mg/capsule)
    • 3g tryptophan per day (2 capsules, t.i.d.), at 8AM, 4PM, and 0AM (± 1 hour)
  • MaltoseDietary supplement

    Maltose

Study groups in NCT04505800
Study groupRoleWhat they receive
Tryptophan supplementExperimental* Pure L-tryptophan in capsules (500mg/capsule) * 3g tryptophan per day (2 capsules, t.i.d.), at 8AM, 4PM, and 0AM (± 1 hour)
Receives: Dietary Supplement: Tryptophan supplement
MaltosePlacebo comparator* Placebo is maltose powder capsule (500mg/capsule) * 3g maltose powder per day (2 capsules, t.i.d.), at 8AM, 4PM, and 0AM (± 1 hour)
Receives: Dietary Supplement: Maltose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Melatonin level in the morning

    Morning (8AM) saliva melatonin level change in the phase

    Measured: 3 weeks

  2. Melatonin level in the afternoon

    Afternoon (4PM) saliva melatonin level change in the phase

    Measured: 3 weeks

  3. Melatonin level at midnight

    Midnight (0AM) saliva melatonin level change in the phase

    Measured: 3 weeks

  4. Cortisol level in the morning

    Morning (8AM) saliva cortisol level change in the phase

    Measured: 3 weeks

  5. Cortisol level in the afternoon

    Afternoon (4PM) saliva cortisol level change in the phase

    Measured: 3 weeks

  6. Cortisol level at midnight

    Midnight (0AM) saliva cortisol level change in the phase

    Measured: 3 weeks

Secondary outcomes (4)
  1. Sleep quality

    Pittsburg Sleep Quality Score (range: 0-21) at the end of the phase. The higher score indicates worse sleep quality

    Measured: 3 weeks

  2. Mood states, depression

    Depression, Anxiety, Stress Scales. Depression score (range 0-42) changes in the phase. The higher score, the more depressed.

    Measured: 3 weeks

  3. Mood states, anxiety

    Depression, Anxiety, Stress Scales. Anxiety score (range 0-42) changes in the phase. The higher score, the more anxious.

    Measured: 3 weeks

  4. Mood states, stress

    Depression, Anxiety, Stress Scales. Stress score (range 0-42) changes in the phase. The higher score, the more stressful.

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2020
  2. Study start1 Sep 2019
  3. Primary completion1 Sep 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04505800
Sponsor's protocol ID
YM106114F
Status last verified
Mar 2021
First submitted
23 Jun 2020
Last updated
22 Mar 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The participants did not provide agreement to the researchers.

Questions about this trial

What is this clinical trial studying?

A study testing Tryptophan supplement and Maltose in people with Sleep and Mood, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Melatonin level in the morning (time frame: 3 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in